#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neurodegenerative disorder Liver transplant rejection Congenital hypotransferrinaemia Short stature Bile acid synthesis disorder Biotinidase deficiency Cholestatic pruritus Porphyria non-acute Glycogen storage disease type I Erdheim-Chester disease Advanced systemic mastocytosis Graft versus host disease Liposarcoma metastatic Henoch-Schonlein purpura nephritis Follicular lymphoma stage I More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma recurrent – Trials in Disease IgA nephropathy – Treatment Rhabdomyosarcoma recurrent – Basic Information Angiosarcoma non-metastatic – Trials in Disease Rhabdomyosarcoma recurrent – Diagnostics Bronchopulmonary dysplasia Basal cell naevus syndrome Breast angiosarcoma metastatic – Diagnostics Angiosarcoma non-metastatic – Diagnostics Mantle cell lymphoma stage III – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rotigotine Isoleucine Mogamulizumab Bi 765845 Vibegron Clonazepam ENSIFENTRINE Juniper Berry Oil Trastuzumab Emtansine 13N-AMMONIA CEFTAROLINE FOSAMIL Nedosiran Isis 678354 Sodium Salt Tusamitamab Ravtansine Esk-001 Pyridoxine Hydrochloride Bp Diltiazem Hydrochloride Afimetoran Besilate Dihydrate Indacaterol Nicotinamide More therapies…

    Learn about Your Condition

    Right ventricular dysfunction Albuminuria Drug use disorder Cartilage injury Mitral valve prolapse Normal pressure hydrocephalus Hodgkin's disease refractory Post procedural infection Systemic mastocytosis Scoliosis Skin angiosarcoma Vulvar dysplasia Myocardial infarction Monkeypox Dyskinesia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vitiligo

  • Phase IIb Randomized, Double‑Blind Study of GIA632 in Adults with Nonsegmental Vitiligo

    Not yet recruiting

    2 1
    France Germany Italy The Netherlands Spain

  • A study to evaluate the effectiveness of oxygen and narrow-band UVB phototherapy for treating patients with diffuse vitiligo

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Vitiligo
    Investigated Drugs:
    • Oxygen
    France

  • A study testing pioglitazone for adults with non-segmental vitiligo to see if it works and is safe when used with light therapy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Vitiligo
    Investigated Drugs:
    • Pioglitazone
    Italy

  • Study on Pioglitazone for Adults with Non-Segmental Vitiligo

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Vitiligo
    Investigated Drugs:
    • Pioglitazone
    Italy

  • A study comparing how ritlecitinib capsules work when sprinkled on food versus swallowed whole and with or without food in healthy adults

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Alopecia areata
    • Rheumatoid arthritis
    • Crohn’s disease
    Belgium

  • Testing delgocitinib cream for patients with vitiligo on the face

    Not recruiting

    2 1 1 1
    Denmark
Previous Page
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!